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Background: Streptococcus pneumoniae is one major cause of pneumonia in human and contains various virulence
factors that contribute to pathogenesis of pneumococcal disease. This study investigated the role of pneumolysin,
Ply, in facilitating S. pneumoniae invasion into the host blood stream.
Methods: S. pneumoniae strains were isolated from clinical blood and sputum samples and confirmed by PCR.
Expression of ply gene was assessed by infecting human monocytes and pneumocytes.
Results: A total of 23 strains of S. pneumoniae isolated from blood (n = 11) and sputum (n = 12) along with
S. pneumoniae ATCC49619 were used to infect human monocyte (THP-1) and Type II pneumocyte (A549) cell lines. All
clinical strains of S. pneumoniae showed higher expression of ply mRNA than the American Type Culture Collection
(ATCC) strain. Among the clinical strains, blood isolates showed higher expression of ply genes than sputum isolates,
i.e., 21.5- to 21.6-folds in THP-1 and 20.4- to 24.9-folds in A549 cell lines.
Conclusions: The data from the current study demonstrated that ply gene of blood- and sputum-derived S. pneumoniae
is differentially expressed in two different cell lines. Under survival pressure, ply is highly expressed in these two
cell lines for blood-derived S. pneumoniae, indicating that ply gene may facilitate S. pneumoniae invasion into the
host blood system.
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Streptococcus pneumoniae (S. pneumoniae) is a gram-
positive diplococcus that is the main pathogenic bacter-
ium of community-acquired pneumonia, otitis media,
meningitis, abscesses, and other infections, particularly
in infants and the elderly [1]. In developing countries,
up to 1 million deaths annually are caused by pneumo-
nia in children less than 5 years of age, in which S. pneu-
moniae is the major pathogenic bacterium [2]. Normally,
S. pneumoniae is colonized in the respiratory tract of
asymptomatic carriers as an opportunistic bacterium [3].
And it is difficult to predict when it converts to patho-
genic bacterium although Manso et al. [4] reported that
such a phase variation consists of genetic rearrangements.* Correspondence: 89434436@qq.com; 1011575993@qq.com
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unless otherwise stated.However, when the host immunosystem becomes weak,
S. pneumoniae will be infectious. During S. pneumoniae
conversion from an opportunistic bacterium to a par-
ticularly pathogenic bacterium that causes severe inva-
sive infections such as blood and cerebrospinal fluid
(CSF) infections, the complex interaction will occur
between S. pneumoniae and the body’s immune system.
In addition, infection could also be due to acquisition of
virulent serotypes not previously part of the colonizing
serotypes, which is named as transformation. Multiple
components of S. pneumoniae, such as capsule and
other virulence factors are involved in triggering the
host immune responses [5-7], while a variety of cells in
the host immune system (such as neutrophils, mono-
cytes/macrophages, and dendritic cells) will be activated
to defend against the infection by either killing the
bacteria or releasing a variety of factors (such as IL-1α,
IL-1β, IL-6, IFN-α, IL-8, and ICAM-1).
The septicemia and meningitis caused by S. pneumo-
niae are much more fatal than that of other types ofs is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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that focus on the mechanism responsible for S. pneumo-
niae invasion into the host blood system and nervous
system [7]. Mahdi et al. [9] confirmed the role of tran-
scription factor SP_0927 in pathogenesis and viru-
lence. Uchiyama et al. [7] reported that neuraminidase
A (NanA) is a virulence factor that facilitates S. pneu-
moniae invasion into the CSF. Ricci et al. [10] re-
ported that pneumococcal surface protein A (PspA)
contributes to pneumococcal meningitis rather than
pneumococcal surface protein C (PspC). Based on pre-
vious studies on S. pneumoniae infection, different
virulence factors in S. pneumoniae are able to induce
multiple reactions from the host immune system. To
date, there are more than 10 virulence factors discov-
ered in S. pneumoniae, including NanA, capsular poly-
saccharide synthesis A (CpsA), choline-binding protein
A (CbpA), pneumococcal surface adhesion A (PsaA),
PspA, PspC, pneumolysin (Ply), and so on [2]. Different
virulence factors may have different functions in contribut-
ing to the different types of S. pneumoniae infections.
Furthermore, study on S. pneumoniae virulence factors
uses human cell lines, such as monocytes or lung epithe-
lial cells. These types of cells are important in our body
to prevent or defend against S. pneumoniae infection.
The major role of monocytes is to kill bacteria and to
trigger leukocyte chemotaxis for immunoreactions,
while lung epithelial cells may function as an antigen
presenter. In addition, type II pneumocytes have long
been known to synthesize and secrete complement com-
ponent C3, providing a target for S. pneumoniae adher-
ence to those cells via CbpA. Thus, both types of cells
are the most commonly used for study of the pathogenic
mechanism of S. pneumoniae in vitro. To date, there is
no report showing which specific virulence factor facili-
tates S. pneumoniae invasion into the host blood system.
Possibly, different virulence factors play different roles in
disease progression. In this paper, only ply expression is
shown. We first isolated S. pneumoniae (23 strains) from
clinical blood and sputum samples. They then infected
monocytes or lung epithelial cell lines and the levels of
ply mRNA expression were analyzed.
Methods
The experimental protocol was established according to
the ethical guidelines of the Helsinki Declaration and
was approved by the Human Ethics Committee of
Taizhou Municipal Hospital, China. Written informed
consent was obtained from individual participants.
Isolation of S. pneumoniae strains
The standard S. pneumoniae strain ATCC49619 was
provided by the Chinese National Center for Medical
Culture Collections (Beijing, China). Twenty-three clinicalS. pneumoniae strains were isolated from different in-
patients at the Second Affiliated Hospital of Wenzhou
Medical University (Wenzhou, Zhejiang, China) in 2009,
which were preserved in 20% glycerin Luria-Bertani
Medium and stored at −80°C; among them, 11 strains
were isolated from blood samples, called blood-derived
S. pneumoniae, and the other 12 strains were isolated from
sputum samples, called sputum-derived S. pneumoniae.
All 23 strains had no duplication and only one strain was
isolated from each selected patient. All S. pneumoniae
strains were identified by the Gram-Positive Identification
Card (GPI) of VITEK-32 automatic microorganism
analyzer (bioMérieux Co., Marcy-Etoile, France) and
confirmed by PCR according to du Plessis [11].
S. pneumoniae culture
A total of 24 S. pneumoniae strains were cultured on
blood agar plates at 37°C in a 5% CO2 incubator
(Thermo Electron Co., Waltham, MA, USA) and ad-
justed to 1.0 McFarland in normal saline, which is used
for infection experiments and RNA extraction.
Cell line and culture
Human monocytes THP-1 and type II pneumocytes
A549 cell lines were obtained from the Cell Bank of
Chinese Academy of Sciences (Shanghai, China) and cul-
tured with RPMI 1640 and F-12 K medium (GIBCO,
CA, USA), respectively, and 10% fetal bovine serum
(Zhejiang Tianhang Biological Technology Co., Zhejiang,
China) plus 1% strep-penicillin (Beijing Solarbio Science &
Technology Co., Beijing, China) in a 37°C humidified incu-
bator (Thermo Electron Co., Waltham, MA, USA) with
95% air and 5% CO2. THP-1 and A549 cells were prepared
at concentrations of 4.0 and 3.0 × 108/L respectively for
the infection experiments and such preparation was con-
ducted between May 2011 and July 2011 at the Center
Laboratory of Experiments, Wenzhou Medical University.
Infection of THP-1 and A549 cell lines with S. pneumoniae
cultures
One milliliter of THP-1 cells was grown in 24-well cul-
ture plates, which were 4.0 × 108/L. One milliliter of
S. pneumoniae cultures from clinical samples and
American Type Culture Collection (ATCC) strains was
then seeded into the 24-well culture plates, which was
1.0 McFarland. The blank control used normal saline
instead of S. pneumoniae. The cells were maintained at
37°C in 5% CO2 for 4 h (25 wells) and 8 h (other
25 wells). At the end of the experiments, all of the cell
cultures plus controls were transferred into 1.5-ml cen-
trifuge tubes and centrifuged for 10 min at 4,000 rpm
and then subjected to RNA isolation and PCR analysis.
For A549 cell cultures, 50 μl of 0.25% trypsin (GIBCO,
Pleasanton, CA, USA) were used to digest the adherent
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was no trypsin used for THP-1 cell suspension culture.
The experiments were repeated at least once and all the
24 S. pneumoniae strains were studied in these two
cell lines.
Semi-quantitative RT-PCR
Total RNA from S. pneumoniae culture was isolated
using a RNA extraction kit from Takara (Dalian, China)
according to the manufacturer’s protocols. The purity of
RNA was determined by the Nanodrop 2000 spectro-
photometer (Thermo Electron Co., Waltham, MA, USA)
and the optical density ratios of OD260/OD280 were all
between 1.8 and 2.2. After that, these RNA samples were
converted to cDNA using 2.0 μl of 5x PrimeScript
Buffer, 0.5 μl PrimeScript Buffer RT Enzyme Mix I,
0.5 μl Oligo dT Primer (50 μM), 0.5 μl Random 6
mers (100 μM), 5.0 μl total RNA, and 1.5 μl RNase
free ddH2O for 15 min at 37°C and then stopped at
85°C for 5 s. After that, real-time PCR analysis was
performed by using 10.0 μl SYBR Premix Ex Taq II
(Takara), 0.8 μl PCR primer each (10 μM), 0.4 μl ROX
Reference Dye II (50x), 2.0 μl RT mixture, and 6.0 μl
ddH2O for pre-degeneration at 95°C for 30 s and then
40 cycles of 95°C for 5 s and 60°C for 34 s in a 7,500
fluorescence quantitative PCR instrument (ABI, San
Ramon, CA, USA). The ply primers were synthesized
according to a previous study [12] (5′-GATGGCAAA
TAAAGCAGTAAATGACT-3′ and 5′-TGATGCCAC
TTAGCCAACAAATCG-3′). The 16S rRNA primers
were synthesized according to reference [13]: (5′-
GGTGAGTAACGCGTAGGTAA-3′ and 5′-ACGATC
CGAAAACCTTCTTC-3′). All the primers were syn-
thesized at Shinegene Co. (Shanghai Shanjing, China).
Levels of 16S rRNA were used as an internal refer-
ence to quantify the level of ply expression in this
study. The blank control was from non-infected cell
lines to replace S. pneumoniae with normal saline.
PCR amplification data were quantified by using ABI
7500 Software v2.0.1. while ‘Threshold’ and ‘Baseline’
were selected as ‘auto’.
Statistical analysis
SPSS17.0 statistical software (SPSS, Chicago, IL, USA)
was used for all statistical analyses. The normality ana-
lysis was performed by using the Kolmogorov-Smirnov
test, and the homogeneity of variance analysis between
two groups using Levene’s test. The mean difference be-
tween clinical S. pneumoniae (including blood and spu-
tum S. pneumoniae samples) and control or ATCC49619
was analyzed using the single-sample t test, and the
comparison of blood- and sputum-derived S. pneumo-
niae samples using analysis of variance for factorial
designs in infection of A549 cells. In addition, thetwo-sample t test was used to determine whether
there is a difference in virulence factor expressions
between blood group and sputum group of S. pneu-
moniae before the infection. The Cochran & Cox
separate variance estimation t test was used among
blood or sputum groups of S. pneumoniae after the
infection of THP-1 cells. P > 0.10 in the normality
test, P > 0.10 in the variance homogeneity test, and
P < 0.05 in mean comparison were considered statis-
tically significant.
Results
Expression of virulence gene ply in S. pneumoniae after
infecting THP-1 and A549 cells
To detect the changes in expression of virulence gene ply
in these S. pneumoniae samples, we used the S. pneumo-
niae samples to infect THP-1 and A549 cells for 4 h and
8 h, respectively.
As shown in Table 1, ΔCt values of the virulence gene
ply were significantly different after blood-derived
S. pneumoniae infected THP-1 cells for 4 h and 8 h
compared to pre-infection, but there was no significant
difference between 4 h and 8 h infection. However, there
was no statistically significant difference in expression of
ply after sputum-derived S. pneumoniae infected THP-1
cells for 4 h and 8 h compared to pre-infection, but the
expression was significantly higher after 8 h infection.
However, compared to the ATCC49619 control, before
and after blood- or sputum-derived S. pneumoniae
infected THP-1 cells, ΔCt values of virulence gene ply had
a significant difference, indicating that the expression of
ply was weaker than ATCC49619 before infection, but ex-
pression of ply was higher than ATCC49619 after infec-
tion. Between blood- and sputum-derived S. pneumoniae,
ΔCt of ply expression were significantly different after they
infected THP-1 cells for 8 h: after infection in THP-1 cells
for 8 h, ply expression of blood-derived S. pneumoniae
was stronger than that of sputum-derived ones. Similar re-
sults of ply expression were obtained from blood-derived
or sputum-derived S. pneumoniae infecting A549 cells for
4 h and 8 h (Table 1).
In A549 cells, there was no statistically significant
difference in expression of virulence gene ply be-
tween the following groups: the blood group vs. the
ATCC49619 standard in 4 h or 8 h cultures, the spu-
tum group vs. the ATCC49619 standard in 4 h cultures
(t = −0.901, −1.049, −1.206, respectively; P = 0.389,
0.319, 0.253, respectively). In contrast, the remaining
comparisons showed significant differences (P < 0.05)
(Tables 1 and 2). Moreover, after both blood- and sputum-
derived S. pneumoniae infected A549 cells, there were sta-
tistically significant differences in expression of virulence
gene ply between blood- and sputum-derived S. pneumo-
niae (F = 6.560, P = 0.014), but 4 h to 8 h culture did not
Table 1 Expression of virulence gene ply after S. pneumoniae infected THP-1 or A549 cells
Groups n ply (△Ct,‾x ± s)
0 h 4 h (THP-1) 8 h (THP-1) 4 h (A549) 8 h (A549)
ATCC 1 16.2 31.5 27.9 21.8 19.1
Blood SP 11 29.2 ± 2.6 24.8 ± 3.2 23.0 ± 1.5 20.4 ± 5.1 18.2 ± 2.9
Sputum SP 12 28.1 ± 2.9 26.3 ± 2.7 24.6 ± 1.4 20.8 ± 3.0 23.3 ± 3.1
Note: △Ct = Mean Ct of tested gene − Mean Ct of control gene. Smaller △Ct means more ply expression. Level of 16S rRNA was used as a control, which expresses
much higher than that of ply. SP, Streptococcus pneumoniae; ATCC, American Type Culture Collection.
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lyzed by a variance of factorial designs. However, inter-
action between samples (including blood and sputum
samples) and infection time points had statistical signifi-
cance (F = 5.061, P = 0.030).
Table 2 showed P values between the following com-
pared groups after S. pneumoniae infected THP-1 cells
due to non-homogeneity of variance. Cochran & Cox
separate variance estimation t test was used to compare
blood and sputum groups of S. pneumoniae after the
infection.
Changes in THP-1 and A549 cell morphology after
S. pneumoniae infection
As shown in Figure 1, the longer time of THP-1 cells
culture with S. pneumoniae, the more deaths THP-1
cells suffered, levels of which were associated with differ-
ent sources of S. pneumoniae isolations and amounts.
Similar data were observed in A549 cell cultures of these
S. pneumoniae samples.Table 2 P values between the following compared groups
after S. pneumoniae infected THP-1 cells
Compared groups t P value
0 h B-SP (n = 11) vs. 0 h S-SP (n = 12) 0.956 0.350
4 h B-SP (n = 11) vs. 4 h S-SP (n = 12) −1.223 0.235
8 h B-SP (n = 11) vs. 8 h S-SP (n = 12) −2.690 0.014
0 h B-SP (n = 11) vs. 4 h B-SP (n = 11) 2.778 0.020
0 h B-SP (n = 11) vs. 8 h B-SP (n = 11) 6.775 <0.001
4 h B-SP (n = 11) vs. 8 h B-SP (n = 11) 1.578 >0.10
0 h S-SP (n = 12) vs. 4 h S-SP (n = 12) 1.561 0.147
0 h S-SP (n = 12) vs. 8 h S-SP (n = 12) 4.341 0.001
4 h S-SP (n = 12) vs. 8 h S-SP (n = 12) 2.034 >0.05
0 h B-SP (n = 11) vs. 0 h ATCC (n = 1) 16.449 <0.001
4 h B-SP (n = 11) vs. 4 h ATCC (n = 1) −6.908 <0.001
8 h B-SP (n = 11) vs. 8 h ATCC (n = 1) −11.154 <0.001
0 h S-SP (n = 12) vs. 0 h ATCC (n = 1) 14.350 <0.001
4 h S-SP (n = 12) vs. 4 h ATCC (n = 1) −6.706 <0.001
8 h S-SP (n = 12) vs. 8 h ATCC (n = 1) −7.859 <0.001
Note: SP, Streptococcus pneumoniae; B-SP, blood SP; S-SP, sputum SP; ATCC,
American Type Culture Collection.Discussion
In the current study, we first isolated and confirmed 23
S. pneumoniae strains from clinical blood and sputum
samples. We then used these 23 S. pneumoniae strains
and ATCC49619 to infect human monocytes and pneu-
mocytes and then analyzed expression of the S. pneumo-
niae virulence gene ply in these 23 strains and
ATCC49619. We found that levels of ply mRNA expres-
sion were much higher in clinical S. pneumoniae
samples than in the ATCC49619 standard and in blood-
derived S. pneumoniae samples than in sputum-derived
ones. This finding demonstrated differential expression
of ply mRNA levels in blood-derived S. pneumoniae after
infecting THP-1 and A549 cells compared to sputum-
derived ones. This study provides indirect molecular evi-
dence that the S. pneumoniae virulence gene ply may
facilitate S. pneumoniae invasion into the host blood
system.
Indeed, Ply is a pore-forming toxin with a molecular
weight of 53 kD and is known as a cholesterol-binding
cytolysin, a key virulence factor for clinical S. pneumo-
niae strains. Ply protein can dissolve cell membranes in
almost all eukaryotes. Specifically, Ply toxin will bind to
a cholesterol-rich membrane using its pore-forming
mechanism and then penetrate into the lipid bilayer of
the cell membrane and oligomerize to form a perfor-
ation on the cell membrane [14]. Ply can also activate
macrophages to execute apoptosis without membrane
pore formation [15]. Thus, Ply toxin has a wide range of
biological activities, such as facilitation of S. pneumoniae
colonization and pathogenicity. Ply can also activate the
classic complement pathway in the human body, inhibit
cough and bactericidal activity and migration of white
blood cells [16], stimulate IL-8 synthesis [17], and in-
crease ICAM-1 and IL-1β secretions [18-20]. The Ply
impact on the immune response to the pneumococcus is
highly dependent on the strain background, thus, it is
surely important of the interaction between specific
virulence factors and other components of the genetic
background of this organism [19]. A recent study also
confirmed the role of ply in biofilm formation, which is
separate from the hemolytic activity responsible for
tissue damage during pneumococcal disease [21]. Our
current data showed that after infecting THP-1 cells,
Figure 1 Morphological changes of THP-1 and A549 cells after Streptococcus pneumoniae (SP) infection. THP-1 and A549 cells began to die after
infection at 4 to 8 h: (A) THP-1 at 0 h; (B) THP-1 (uninfected control) at 4 h; (C) THP-1 (uninfected control) at 8 h; (D) THP-1 with SP at 4 h;
(E) THP-1 with SP at 8 h; (F) A549 at 0 h; (G) A549 (uninfected control) at 4 h; (H) A549 (uninfected control) at 8 h; (I) A549 with SP at 4 h;
(J) A549 with SP at 8 h. (A-J: ×400). One strain of blood-derived SP was used except in the uninfected control. 0 h means before infection.
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blood-derived S. pneumoniae strains compared to
sputum-derived ones, indicating that the increased ply
expression may contribute to S. pneumoniae against
defense of THP-1 cells, which may be one of the mecha-
nisms for S. pneumoniae invasion into the host blood
system. In the current study, we determined ply expres-
sion after infecting two types of human cell lines and
data are identical, which are consistent with a previous
study [22]. Besides, as a whole, expression of psaA and
cpsA was also studied in a previous study [23]. And
different patterns of their expression clearly showed
different roles of such three virulence genes. The ex-
pression of cpsA is the basis of the pathogenicity of SP
and ply expression is more important than that of
psaA in SP invasion into the blood system. Our
current data demonstrated that inflammation induction
of different SP sources tends to be consistent [20]. How-
ever, the infection types are determined mainly by differ-
ent sources of SP itself, especially its expression of
virulence genes.
In the current study, we utilized a standard strain of
S. pneumoniae ATCC49619 for comparison. We found
that S. pneumoniae isolated from both blood and spu-
tum samples were more virulent by expression of high
levels of Ply toxin after infecting THP-1 and A549 cells.
ATCC49619 is a standard S. pneumoniae strain and its
physical and chemical properties are relatively stable.
The S. pneumoniae isolated from clinical samples were
much more easily influenced by external environment
than ATCC49619. Thus, compared to clinical S. pneu-
moniae, the levels of virulence and viability of
ATCC49619 are weaker, all of which may indicate that
clinical S. pneumoniae strains are more infectious.However, it remains to be determined whether S. pneu-
moniae isolated from different individuals also have dif-
ferent levels of infection potential.
Moreover, we also showed the interaction between
S. pneumoniae and THP-1 cells or A549 cells. Different
sources of S. pneumoniae resulted in different outcomes,
which could suggest that various strains of S. pneumo-
niae have different abilities to infect the lung, blood, or
even the CSF. However, this study is just a proof-of-
principle and much more are needed to investigate other
virulence factors of S. pneumoniae or their combinations
in infecting the human body. Indeed, S. pneumoniae
have many other virulence genes, such as nanA [7],
which has been demonstrated to facilitate S. pneumoniae
invasion into the CSF. Moreover, S. pneumoniae inva-
sion into the host blood system is an important step and
prerequisite for its further invasion into the CSF in most
cases. The role of Ply toxin in S. pneumoniae invasion
into the host blood system and its relationship with
NanA are worthy of further investigation. In addition,
the significance of this in vitro study needs further con-
firmation by an in vivo study.
Conclusions
The current study demonstrated that ply gene of blood-
and sputum-derived S. pneumoniae is differentially ex-
pressed in two different cell lines. Under survival
pressure, higher expression of ply gene is needed in
these two cell lines for blood-derived S. pneumoniae,
which indicates that ply gene may facilitate S. pneumo-
niae invasion into the host blood system.
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